About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 35211301 Journal: Clinical Kidney Journal Year: 2022 Reference: Clin Kidney J. 2021 Sep 28;15(3):417-424. doi: 10.1093/ckj/sfab176. eCollection 2022 Mar. Impact factor: 4.452 Publication type: Review in international publication Authors: Crespo, Marta, Rodriguez, Eva, Gabaldon, Alejandra, Soler, Maria Jose, Lop, Joan, Ribas, Andres, Puche, Adrian, Gimeno, Javier, Sans, Laia, Barrios, Clara et al. DOI: 10.1093/ckj/sfab176
PMID: 35171022 Journal: Microbiology Spectrum Year: 2022 Reference: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16. Impact factor: 7.171 Publication type: Paper in international publication Authors: Monforte, Arnau, Los-Arcos, Ibai, Martin-Gomez, Maria Teresa, Campany-Herrero, David, Sacanell, Judith, Berastegui, Cristina, Marquez-Algaba, Ester, Sempere, Abiu, Nuvials, Xavier, Castells, Lluis et al. DOI: 10.1128/spectrum.01784-21
PMID: 35053290 Journal: Biomolecules Year: 2022 Reference: Biomolecules. 2022 Jan 16;12(1). pii: biom12010143. doi: 10.3390/biom12010143. Impact factor: 4.879 Publication type: Review in international publication Authors: Llorens-Cebria, Carmen, Molina-Van den Bosch, Mireia, Vergara, Ander, Jacobs-Cacha, Conxita, Soler, Maria Jose et al. DOI: 10.3390/biom12010143
PMID: 34873314 Journal: Nature Reviews Nephrology Year: 2022 Reference: Nat Rev Nephrol. 2022 Feb;18(2):80-81. doi: 10.1038/s41581-021-00521-4. Impact factor: 28.314 Publication type: Review in international publication Authors: Soler, Maria Jose, Jacobs-Cacha, Conxita et al. DOI: 10.1038/s41581-021-00521-4
PMID: 33632558 Journal: NEFROLOGIA Year: 2021 Reference: Nefrologia. 2021 Jul-Aug;41(4):476-478. doi: 10.1016/j.nefro.2020.12.008. Epub 2021 Jan 28. Impact factor: 2.033 Publication type: Letter or abstract Authors: Zuniga, Jose, Toapanta, Nestor, Ramos, Natalia, Caparros, Sonia, Leon-Roman, Juan, Azancot, Maria, Garcia-Carro, Clara, Espinel, Eugenia, Seron, Daniel, Soler, Maria Jose et al. DOI: 10.1016/j.nefro.2020.12.008
PMID: 33623672 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2020 Aug 11;14(2):482-491. doi: 10.1093/ckj/sfaa110. eCollection 2021 Feb. Impact factor: 4.452 Publication type: Review in international publication Authors: Toapanta-Gaibor, Nestor, Ariceta, Gema, Moreso, Francesc, Seron, Daniel, Lopez-Hellin, Joan, Soler, Maria Jose, Agraz, Irene, Garcia-Carro, Clara, Jacobs-Cacha, Conxita, Vergara, Ander et al. DOI: 10.1093/ckj/sfaa110
PMID: 33617203 Journal: TRANSPLANTATION Year: 2021 Reference: Transplantation. 2021 Mar 1;105(3):648-659. doi: 10.1097/TP.0000000000003274. Impact factor: 4.939 Publication type: Paper in international publication Authors: Djamali, Arjang, Irish, William, Nickerson, Peter, Astor, Brad C, Chong, Edward, Wiebe, Chris, Moreso, Francesc, Seron, Daniel, Crespo, Marta, Gache, Larry et al. DOI: 10.1097/TP.0000000000003274
PMID: 33599030 Journal: CLINICAL TRANSPLANTATION Year: 2021 Reference: Clin Transplant. 2021 May;35(5):e14256. doi: 10.1111/ctr.14256. Epub 2021 Feb 27. Impact factor: 2.863 Publication type: Paper in international publication Authors: Jimenez, C, Perez-Mir, M, Martin-Moreno, P L, Sanchez-Fructuoso, A I, Mir, M, Lopez-Lopez, I, Gonzalez-Rinne, A, Coca, A, Valero, R, Ventura Galiano, A et al. DOI: 10.1111/ctr.14256
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.
The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.
